CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 22,337 shares at $5.61 ($125,404)
- 4 Open-market buy Director bought 45,000 shares at $5.64 ($253,868)
- 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 61,266 shares (grant or award)
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 39,855 shares (grant or award)
- 4 Planned sale CEO sold 77,824 shares at $9.42 ($732,884)
- 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 20,327 shares at $9.42 ($191,425)
- 4 Planned sale EVP, CBO AND CTO sold 103 shares at $10.90 ($1,122)
- 4 Planned sale EVP, CBO AND CTO sold 695 shares at $8.21 ($5,706)
- 4 Planned sale EVP, CBO AND CTO sold 139 shares at $8.40 ($1,168)
- 4 Planned sale EVP, CBO AND CTO sold 103 shares at $8.82 ($908)
- 4 Planned sale EVP, CBO AND CTO sold 702 shares at $8.59 ($6,033)
- 4 Planned sale EVP, CBO AND CTO sold 141 shares at $8.39 ($1,183)
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 45,167 shares (grant or award)
Page 4 of 18 · 351 filings